ALSAF — Safe SA Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- €0.00m
- €9.59m
- €5.86m
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.47 | 4.7 | 3.66 | 4.55 | 5.86 |
Cost of Revenue | |||||
Gross Profit | 1.51 | 1.28 | 1.4 | 2.57 | 4.11 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.62 | 12.1 | 10.3 | 12.1 | 11.8 |
Operating Profit | -6.15 | -7.45 | -6.67 | -7.58 | -5.96 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.8 | -7.97 | -8.31 | -6.71 | -6.97 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.8 | -7.97 | -8.31 | -6.71 | -6.96 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.8 | -7.97 | -8.31 | -6.71 | -6.96 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.8 | -7.97 | -8.31 | -6.71 | -6.96 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -44,667 | -61,308 | -7,585 | -10,418 | -18.2 |
Dividends per Share |